Literature DB >> 3000941

Differential effects of monoHETEs (monohydroxyeicosatetraenoic acids) on arachidonic acid metabolism in glycogen-elicited rat polymorphonuclear leukocytes.

J Chang, M D Skowronek, A J Lewis.   

Abstract

We investigated the effects of monohydroxyeicosatetraenoic acids (monoHETEs) on lipoxygenase- and cyclooxygenase-catalyzed reactions in glycogen-elicited rat PMNs challenged with A23187 and exogenous [14C]arachidonic acid. A23187 (10 microM) stimulated a 10-, 4-, 1.7- and 1.8-fold increase in the synthesis of radiolabeled 5-HETE, LTB4, TxB2, and PGE2 by rat PMNs. Addition of 5-HETE, 5 lactone-HETE, 12-HETE, and 15-HETE led to a dose-related reduction in [14C]5-HETE and [14C]LTB4 synthesis by these cells. These monoHETEs also inhibited [14C]TxB2 synthesis, but only 5-HETE and 5 lactone-HETE inhibited the synthesis of [14C]PGE2. Both 12-HETE and 15-HETE failed to reduce the formation of [14C]PGE2. These results suggest that monoHETEs differ significantly in their effects on arachidonic acid metabolism in rat PMNs and may play a role in modulating the synthesis of both lipoxygenase and cyclooxygenase products.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3000941     DOI: 10.1007/bf00916339

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  26 in total

Review 1.  Prostaglandins and thromboxanes: biochemical and physiological considerations.

Authors:  B Samuelsson; G Folco; E Granström; H Kindahl; C Malmsten
Journal:  Adv Prostaglandin Thromboxane Res       Date:  1978

2.  Comparative effects of indomethacin, acetylenic acids, 15-HETE, nordihydroguaiaretic acid and BW755C on the metabolism of arachidonic acid in human leukocytes and platelets.

Authors:  H Salari; P Braquet; P Borgeat
Journal:  Prostaglandins Leukot Med       Date:  1984-01

3.  Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides.

Authors:  R J Gryglewski; S Bunting; S Moncada; R J Flower; J R Vane
Journal:  Prostaglandins       Date:  1976-11

4.  Arachidonic acid metabolism in polymorphonuclear leukocytes: effects of ionophore A23187.

Authors:  P Borgeat; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1979-05       Impact factor: 11.205

5.  Diglyceride lipase: a pathway for arachidonate release from human platelets.

Authors:  R L Bell; D A Kennerly; N Stanford; P W Majerus
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

6.  Stimulation of leukotriene biosynthesis in human blood leukocytes by platelet-derived 12-hydroperoxy-icosatetraenoic acid.

Authors:  J Maclouf; B F de Laclos; P Borgeat
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

7.  Regulation of leukocyte and platelet lipoxygenases by hydroxyeicosanoids.

Authors:  J Y Vanderhoek; R W Bryant; J M Bailey
Journal:  Biochem Pharmacol       Date:  1982-11-01       Impact factor: 5.858

8.  Modulation by hydroxyeicosatetraenoic acids (HETEs) of arachidonic acid metabolism in mouse resident peritoneal macrophages.

Authors:  J Chang; B Lamb; L Marinari; A F Kreft; A J Lewis
Journal:  Eur J Pharmacol       Date:  1985-01-02       Impact factor: 4.432

9.  Preparation and characterization of hydroperoxy-eicosatetraenoic acids (HPETEs).

Authors:  J M Boeynaems; J A Oates; W C Hubbard
Journal:  Prostaglandins       Date:  1980-01

10.  Metabolism of arachidonic acid in polymorphonuclear leukocytes. Structural analysis of novel hydroxylated compounds.

Authors:  P Borgeat; B Samuelsson
Journal:  J Biol Chem       Date:  1979-08-25       Impact factor: 5.157

View more
  1 in total

1.  The suppression of 5-lipoxygenation of arachidonic acid in human polymorphonuclear leucocytes by the 15-lipoxygenase product (15S)-hydroxy-(5Z,8Z,11Z,13E)-eicosatetraenoic acid: structure-activity relationship and mechanism of action.

Authors:  K Petrich; P Ludwig; H Kühn; T Schewe
Journal:  Biochem J       Date:  1996-03-15       Impact factor: 3.857

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.